Related Experiment Video
Updated: Dec 6, 2025

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Relationship of miRNA-146a to systemic lupus erythematosus: A PRISMA-compliant meta-analysis
Yihua Fan1,2, Yue Ji2,3, Xuyan Wang4
1Department of Rheumatism and Immunity, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine.
Background And Objective:
miRNA-146a is a microRNA that plays an important role in systemic lupus erythematosus (SLE). Several studies have examined the role of miRNA-146a in SLE, but have demonstrated equivocal or even contradictory conclusions. Therefore, this meta-analysis aimed to assess the role of miRNA-146a in SLE by examining data from previous studies.
Methods:
A meta-analysis of relevant papers published before August 31, 2019, in the WanFang, Chinese Biomedical Literature Database (CBM), Chinese National Knowledge Infrastructure (CNKI), PubMed, EMBASE, and Web of Science databases was performed to verify the relationship of miRNA-146a expression level to SLE. Two investigators independently extracted the data and conducted a quality assessment of the studies. All statistical analyses were performed using Stata 14.0. Trial sequence analysis (TSA) was conducted to assess the quality and strength of the studies using the TSA software.
Results:
Six publications, involving 151 SEL patients and 132 healthy individuals as controls were included in this meta-analysis. The results showed that the expression of miRNA-146a was associated with SLE risk [standard mean difference (SMD) = -1.21, 95% confidence interval (95% CI) (-2.18, -0.23), P = .015]. The stratified analysis revealed that the expression of miRNA-146a was highly related to higher SLE risk among Asian (SMD = -1.30, 95% CI (-2.52, -0.07), P = .038) and Caucasian (SMD = -0.72, 95% CI (-1.20, -0.24), P = .003) populations. Besides, the serum levels of miRNA146a were significantly different (SMD = -1.73, 95% CI (-3.11, -0.36), P = .014). The TSA revealed that the cumulative Z-curve crossed the typical boundary value, and reached the TSA monitoring boundary, but did not reach the required information size. This indicates that even if the cumulative sample size did not meet required information size, no more trials were needed and a reliable conclusion was reached in advance. Sensitivity analyses indicated the instability of the meta-analysis.
Conclusions:
Overall, the expression of miRNA-146a is associated with SLE risk. Therefore, miRNA-146a is a promising candidate for the effective diagnosis of SLE. But, due to the limitations of this study, it is necessary to cautiously explain the results of this study.
Systematic Review Registration:
PROSPERO CRD42019151381.
Insights
This meta-analysis found that miRNA-146a expression is linked to an increased risk of systemic lupus erythematosus (SLE). Despite study limitations, miRNA-146a shows potential as a diagnostic marker for SLE.
Area of Science:
- Immunogenetics
- Molecular Biology
- Autoimmune Diseases
Background:
- Systemic lupus erythematosus (SLE) is an autoimmune disease with complex pathogenesis.
- MicroRNA-146a (miRNA-146a) has been implicated in SLE, but previous studies yielded conflicting results.
- A comprehensive meta-analysis is needed to clarify the role of miRNA-146a in SLE.
Purpose of the Study:
- To systematically evaluate the association between miRNA-146a expression levels and the risk of developing SLE.
- To synthesize evidence from existing studies to provide a more definitive conclusion on miRNA-146a's role in SLE pathogenesis.
Main Methods:
- A meta-analysis was conducted on studies published up to August 31, 2019, searching multiple databases.
- Data extraction and quality assessment were performed independently by two investigators.
- Statistical analyses included standard mean difference (SMD) calculations and Trial Sequence Analysis (TSA) for robustness.
Main Results:
- Six studies with 151 SLE patients and 132 controls were included.
- A significant association was found between miRNA-146a expression and SLE risk (SMD = -1.21, P = .015).
- Stratified analyses indicated a higher risk in Asian and Caucasian populations; serum levels also differed significantly. TSA suggested reliable conclusions despite not meeting the required information size.
Conclusions:
- miRNA-146a expression is significantly associated with an increased risk of SLE.
- miRNA-146a is a potential biomarker for SLE diagnosis.
- Further research is warranted due to study limitations and sensitivity analysis indicating instability.
More Related Videos
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
MicroRNAs
lncRNA - Long Non-coding RNAs
Non-LTR Retrotransposons

